Success stories Dec 08, 2023 “Our first choice was and will always be Switzerland" M&K Global AG is a Bern-based holding company focusing on strategies for drone service integration, real-world implementation and education. ...
News May 24, 2023 Latest research shows 20% of European biotechs now headquartered in Switzerland Press release New research conducted by IQVIA and recently published in the 2023 Swiss Biotech Report shows that 20% of European biotech companies are now head...
Commercial HQ in Switzerl... May 09, 2023 Commercial HQ in Switzerland Setting up Your Commercial HQ in Switzerland: The Key to European Market Success: Are you a pharmaceutical company seeking to access the European...
Actualités Jun 02, 2023 UNE ÉTUDE RÉCENTE MONTRE QUE 20 % DES SOCIÉTÉS DE BIOTECHNOLOGIE EUROPÉENNES ONT DÉSORMAIS LEUR SIÈGE EN SUISSE Press release Une nouvelle étude menée par IQVIA et récemment publiée dans le Swiss Biotech Report 2023 montre que 20 % des sociétés de biotechnologie eur...
Novità Jun 02, 2023 Le ultime ricerche indicano che il 20% delle aziende biotecnologiche europee ha attualmente sede in Svizzera Press release Una nuova ricerca condotta da IQVIA e pubblicata recentemente nello Swiss Biotech Report 2023 mostra che il 20% delle aziende biotecnologiche eur...
Headquarters Jun 15, 2023 Open Your HQ Are you a biopharmaceutical company seeking to access the European market? Switzerland could be the perfect location for your commercial headquar...
总部 Jun 27, 2023 设立您的公司总部 您是一家寻求进入欧洲市场的生物制药公司吗?瑞士可能是设立商业总部或区域中心的理想地点,可帮助您的企业覆盖整个欧洲,以及欧洲、中东和非洲市场的运营。瑞士的吸引力包括地处欧洲中心的战略位置、商业友好型的营商环境、有竞争力的公司和个人税收制度以及多样化的人才市场。默克雪兰诺(Merck Sero...
Expertise Feb 08, 2023 Switzerland: A Global Leader in Blockchain Education and Research Switzerland is renowned for its highly skilled and international workforce and is ranked first in INSEAD Global Talent Competitiveness Index for ...
Expertise Feb 08, 2023 Attracting Companies from Around the World with Favorable Regulations and a Pro-Innovation Stance Switzerland has become a leading destination for blockchain and cryptocurrency companies, attracting firms from around the world due to its favor...
Aktuell Jun 02, 2023 Neuste Forschung zeigt, dass 20% der europäischen Biotechs ihren Hauptsitz in der Schweiz haben Press release Neue Untersuchungen von IQVIA, die kürzlich im Swiss Biotech Report 2023 veröffentlicht wurden, zeigen, dass mittlerweile 20% der europäischen Bi...
Success stories Jan 12, 2021 European Headquarters and Tech Hub in Rotkreuz Align Technology Align Technology is a leading medical device company in the dental industry with headquarters in California and over 17,000 employees worldwide.&...
Success stories Dec 12, 2023 "LA NOSTRA PRIMA SCELTA È STATA E SARÀ SEMPRE LA SVIZZERA" M&K Global AG è una holding con sede a Berna che si occupa di strategie per l’integrazione dei servizi con droni, implementazione nel mondo r...
Success stories Feb 22, 2022 Incepto Medical: "We believed that in Switzerland we could find complementary people to strengthen our teams." Incepto Medical Incepto Medical is a Paris-based company that co-creates and distributes AI apps for medical imaging. Their goal is to be the “Netflix of medical...
本社 Jun 14, 2023 製薬、医療技術事業会社の欧州本部 欧州市場への参入を目指す日本のバイオ医薬品企業にとって、スイスは、欧州本部、また欧州・中東・アフリカ事業の地域統括拠点として最適な場所です。地理的なメリット、ビジネスのしやすさ、多様な人材の集積地であることなどが魅力となり、メルクセローノ、武田薬品工業、バイオジェン、ジョンソン・エンド・ジ...
Exemples de Réussite Dec 12, 2023 “NOTRE PREMIER CHOIX A ÉTÉ ET SERA TOUJOURS LA SUISSE" M&K Global AG est une holding bernoise spécialisée dans les stratégies d’intégration des services de drones, de mise en œuvre en situation ré...
ニュース Jun 02, 2023 欧州のバイオテクノロジー企業の20%がスイスに本社を置いていることが判明 Press release IQVIAが実施し、このほど発表された「2023スイスバイオテックレポート」によると、欧州のバイオテクノロジー企業の20%がスイスに本社を置いていることが明らかになりました。さらに、スイス連邦政府、州、地域による投資促進に関する昨年の統計でも、この傾向が続いていることが確認されています。
Spotlight Jun 15, 2023 Access to Ecosystem Switzerland is a global leader in biotech, medtech and pharma. Find out what makes the Swiss life science industry unique and how your life scien...
最新 Jun 02, 2023 最新研究显示,目前有20%的欧洲生物科技公司将总部设在瑞士 Press release 由 IQVIA 进行的新研究和最近发布的《2023瑞士生物科技报告》显示,目前有20%的欧洲生物科技公司将总部设在瑞士。此外,瑞士联邦政府、各州和地区去年的投资促进统计数据证实,这一趋势仍在继续。